About Intrauterine devices
Intrauterine devices (IUDs) are contraceptive medical implants used to prevent pregnancies for a long period of time. They are also known as long-acting reversible contraceptive devices. An IUD is a T-shaped device, made of flexible plastic, with a copper wire wrapped around its stem, and is considered a safe and reliable method of sterilization for women. It is inserted into the uterus, and its primary aim is to prevent the fertilization of the egg by causing changes, such as thickening or toxicity of the cervical mucus, thus preventing fertilization by a sperm. There are two types of IUDs, namely, copper IUD (containing copper) and hormone-releasing IUDs (containing the progesterone hormone). Mirena and ParaGard are some of the prominent brands available in the market.
Technavio's analysts forecast the global intrauterine devices market to grow at a CAGR of 3.44% over the period 2014-2019.
Covered in this report
In this report, Technavio covers the present scenario and growth prospects of the global intrauterine devices market for 2015-2019. To calculate the market size, the report considers revenue generated from the sales of following type of products: Hormonal IUDs and copper IUDs.
Technavio's report, Global intrauterine devices market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report also presents the vendor landscape and a corresponding detailed analysis of the top three vendors in the market. Also, it discusses the major drivers and challenges in the market, as well as the key trends.
Key regions
• Americas
• APAC
• EMEA
Key vendors
• Actavis
• Bayer
• Teva Pharmaceutical
Other prominent vendors
• Besins HealthCare
• Brecuro Medical
• Effik International
• Eurogine
• HLL Lifecare
• HRA Pharma
• Medisafe Distribution
• OCON Medical
• Pregna
• SMB
• Tespro
• Trimedic Supply Network
Market driver
• Long-term efficacy and increased acceptance of IUDs
• For a full, detailed list, view our report
Market challenge
• Lack of social acceptance
• For a full, detailed list, view our report
Market trend
• Increased institutional funding for IUDs
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
PART 01: Executive summary
PART 02: Scope of the report
Market overview
Top-vendor offerings
PART 03: Market research methodology
Research methodology
Economic indicators
PART 04: Introduction
Key market highlights
PART 05: About intrauterine devices
PART 06: Reimbursement scenario in US
Purchase discounts by vendors for leading IUD brands
Medical coverage of LARC methods
Commercial insurance coverage LARC methods
PART 07: Market landscape
Market overview
Market size and forecast
Five forces analysis
PART 08: Market segmentation by product type
Hormonal intrauterine devices
Copper intrauterine devices
PART 09: Geographical segmentation
Intrauterine devices market in Americas
Intrauterine devices market in EMEA
Intrauterine devices market in APAC
PART 10: Market drivers
PART 11: Impact of drivers
PART 12: Market challenges
PART 13: Impact of drivers and challenges
PART 14: Market trends
PART 15: Vendor landscape
Vendor investment opportunities in different countries
Market share analysis 2014
Other prominent vendors
PART 16: Key vendor analysis
Bayer HealthCare
Teva Pharmaceuticals
Actavis
PART 17: Appendix
List of abbreviations
PART 18: Explore Technavio
List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Number of intrauterine device users in major countries
Exhibit 03: Different plans available for contraception methods
Exhibit 04: Global intrauterine devices market ($ billions)
Exhibit 05: Five forces analysis
Exhibit 06: Segmentation of global intrauterine devices market by product type
Exhibit 07: Segmentation of global intrauterine devices market by product type
Exhibit 08: Segmentation of global intrauterine devices market by geography 2014
Exhibit 09: Intrauterine devices market in Americas 2014-2019 ($ billions)
Exhibit 10: Intrauterine device prevalence rate in North America in 2013
Exhibit 11: Intrauterine device prevalence rate in South America in 2013
Exhibit 12: Intrauterine devices market in EMEA 2014-2019 ($ billions)
Exhibit 13: Intrauterine device prevalence rate in EMEA in 2013
Exhibit 14: Intrauterine devices market in APAC 2014-2019 ($ billions)
Exhibit 15: Intrauterine device prevalence rate in APAC in 2013
Exhibit 16: Segmentation of global intrauterine devices market by geography 2014-2019 ($ millions)
Exhibit 17: Segmentation of global intrauterine devices market by geography 2014-2019 (%)
Exhibit 18: Effectiveness of female contraception by types
Exhibit 19: Classification of modern IUDs
Exhibit 20: Percentage of couples using modern method of contraception (IUD)
Exhibit 21: Impact of drivers
Exhibit 22: Impact of drivers and challenges
Exhibit 23: Unintended pregnancies by region (%)
Exhibit 24: Actavis: Key takeaways
Exhibit 25: Bayer: Key takeaways
Exhibit 26: Teva Pharmaceutical: Key takeaways
Exhibit 27: Bayer HealthCare: Business segmentation by revenue 2014
Exhibit 28: Bayer HealthCare: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 29: Bayer HealthCare: Geographical segmentation by revenue 2014
Exhibit 30: Teva Pharmaceuticals: Business segmentation by revenue 2014
Exhibit 31: Teva Pharmaceuticals: Business segmentation by revenue 2013 and 2014
Exhibit 32: Teva Pharmaceuticals: Geographical segmentation by revenue 2014
Exhibit 33: Actavis: Business segmentation by revenue 2014
Exhibit 34: Actavis: Business segmentation by revenue 2013 and 2014
